List of Micromet patents

Patents where

Current Assignee

Name

Micromet

Name	Description	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 7229760 mRNA amplification	Patent 7229760 was granted and assigned to Micromet on June, 2007 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7229760	June 12, 2007
‌ US Patent 8236308 Composition comprising cross-species-specific antibodies and uses thereof	Patent 8236308 was granted and assigned to Micromet on August, 2012 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	8236308	August 7, 2012
‌ US Patent 7323440 De-immunized MOG (poly)peptide constructs	Patent 7323440 was granted and assigned to Micromet on January, 2008 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7323440	January 29, 2008
‌ US Patent 7112324 CD 19×CD3 specific polypeptides and uses thereof	Patent 7112324 was granted and assigned to Micromet on September, 2006 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7112324	September 26, 2006
‌ US Patent 7575923 CD19xCD3 specific polypeptides and uses thereof	Patent 7575923 was granted and assigned to Micromet on August, 2009 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7575923	August 18, 2009
‌ US Patent 8101722 Less immunogenic binding molecules	Patent 8101722 was granted and assigned to Micromet on January, 2012 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	8101722	January 24, 2012
‌ US Patent 8076459 Multispecfic deimmunized CD3-binders	Patent 8076459 was granted and assigned to Micromet on December, 2011 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	8076459	December 13, 2011
‌ US Patent 7820166 Potent T cell modulating molecules	Patent 7820166 was granted and assigned to Micromet on October, 2010 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7820166	October 26, 2010
‌ US Patent 7635472 Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders	Patent 7635472 was granted and assigned to Micromet on December, 2009 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7635472	December 22, 2009
‌ US Patent 8394926 Pharmaceutical compositions with resistance to soluble CEA	Patent 8394926 was granted and assigned to Micromet on March, 2013 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	8394926	March 12, 2013
‌ US Patent 7235641 Bispecific antibodies	Patent 7235641 was granted and assigned to Micromet on June, 2007 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7235641	June 26, 2007
‌ US Patent 8007796 Means and methods for the treatment of tumorous diseases	Patent 8007796 was granted and assigned to Micromet on August, 2011 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	8007796	August 30, 2011
‌ US Patent 7919089 Pharmaceutical composition comprising a bispecific antibody for EpCAM	Patent 7919089 was granted and assigned to Micromet on April, 2011 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7919089	April 5, 2011
‌ US Patent 7435549 Method of identifying binding site domains that retain the capacity of binding to an epitope	Patent 7435549 was granted and assigned to Micromet on October, 2008 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7435549	October 14, 2008
‌ US Patent 7332168 Composition for the elimination of autoreactive B-cells	Patent 7332168 was granted and assigned to Micromet on February, 2008 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7332168	February 19, 2008
‌ US Patent 7227002 Human antibodies that bind human 17-A1/EpCAM tumor antigen	Patent 7227002 was granted and assigned to Micromet on June, 2007 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7227002	June 5, 2007
‌ US Patent 7632925 Antibodies that bind human 17-A1/EpCAM tumor antigen	Patent 7632925 was granted and assigned to Micromet on December, 2009 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7632925	December 15, 2009
‌ US Patent 8247194 Preparation of scFv antibody fragments	Patent 8247194 was granted and assigned to Micromet on August, 2012 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	8247194	August 21, 2012
‌ US Patent 8017748 Antibody neutralizers of human granulocyte macrophage colony stimulating factor	Patent 8017748 was granted and assigned to Micromet on September, 2011 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	8017748	September 13, 2011
‌ US Patent 7964707 Anti-IL2 antibodies	Patent 7964707 was granted and assigned to Micromet on June, 2011 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7964707	June 21, 2011
‌ US Patent 8840888 Dosage regimen for administering a CD19XCD3 bispecific antibody	Patent 8840888 was granted and assigned to Micromet on September, 2014 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	8840888	September 23, 2014
‌ US Patent 7976842 Treatment of metastatic breast cancer	Patent 7976842 was granted and assigned to Micromet on July, 2011 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7976842	July 12, 2011
‌ US Patent 7105638 Product and process for the production, isolation, and purification of recombinant polypeptide	Patent 7105638 was granted and assigned to Micromet on September, 2006 by the United States Patent and Trademark Office.	Micromet	United States Patent and Trademark Office	7105638	September 12, 2006

23 results

0 selected

23 results

0 selected